Speaker: 

David Ermak, MD, Staff Member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Assess the efficacy and safety of LAA occlusion after stroke

• Examine how LAA occlusion can fit into our stroke prevention paradigm

Follow-Up Questions

• What are the available methods for stroke prevention in patients with atrial fibrillation?
• What are the current indications for left atrial appendage occlusion?
• How does left atrial appendage occlusion compare to anticoagulation? 

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Anthony Noto, MD; Laura Fierke, PA-C and Lisa Wasko, BSN RN SCRN have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant.